Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

mega labs s.a - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....5.00 mg / clonixinato de lisina....125.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios lafi ltda. - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....10 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios laprin, s.a. - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....10 mg.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios laprin, s.a. - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....5.0 mg.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

eurofarma guatemala, s.a. - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....5.000 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

eurofarma guatemala, s.a. - ciclobenzaprina clorhidrato - ciclobenzaprina clorhidrato....10 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

megapharma labs de ceam, s.a. - clonixinato de lisina - clonixinato de lisina....125.00mg / ciclobenzaprina clorhidrato....5.00mg

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine hydrochloride 5 mg - cyclobenzaprine hydrochloride tablets, usp is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hydrochloride tablets, usp should be used only for short periods (up to two or three weeks) because adequate  evidence of effectiveness for more prolonged use is not available and because muscle spasm associated  with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hydrochloride tablets, usp have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao) in

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine hydrochloride 7.5 mg - cyclobenzaprine hydrochloride tablets, usp are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hydrochloride tablets, usp are should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hydrochloride tablets, usp have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao